 
                        | Product NDC: | 55154-5618 | 
| Proprietary Name: | Jantoven | 
| Non Proprietary Name: | Warfarin Sodium | 
| Active Ingredient(s): | 2 mg/1 & nbsp; Warfarin Sodium | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 55154-5618 | 
| Labeler Name: | Cardinal Health | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA040416 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20100223 | 
| Package NDC: | 55154-5618-0 | 
| Package Description: | 10 BLISTER PACK in 1 BAG (55154-5618-0) > 1 TABLET in 1 BLISTER PACK | 
| NDC Code | 55154-5618-0 | 
| Proprietary Name | Jantoven | 
| Package Description | 10 BLISTER PACK in 1 BAG (55154-5618-0) > 1 TABLET in 1 BLISTER PACK | 
| Product NDC | 55154-5618 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Warfarin Sodium | 
| Dosage Form Name | TABLET | 
| Route Name | ORAL | 
| Start Marketing Date | 20100223 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Cardinal Health | 
| Substance Name | WARFARIN SODIUM | 
| Strength Number | 2 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Vitamin K Antagonist [EPC],Vitamin K Inhibitors [MoA] |